(Q34931975)

5 August 2017

1 reference

title

Unravelling the pathogenesis of myasthenia gravis (English)

1 reference

5 August 2017

0 references

0 references

1

Angela Vincent

1 reference

5 August 2017

publication date

1 October 2002

1 reference

Nature Reviews Immunology

5 August 2017

published in

1 reference

5 August 2017

volume

2

1 reference

5 August 2017

issue

10

1 reference

5 August 2017

page(s)

797-804

1 reference

Über humorale übertragbarkeit der Herznervenwirkung

5 August 2017

cites work

1 reference

Release of acetylcholine at voluntary motor nerve endings

31 March 2020

1 reference

AN ELECTROPHYSIOLOGICAL INVESTIGATION OF NEUROMUSCULAR TRANSMISSION IN MYASTHENIA GRAVIS.

31 March 2020

1 reference

Acetylcholine receptors in muscle fibres

31 March 2020

1 reference

Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine Receptors

31 March 2020

1 reference

Primary structure of α-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence

31 March 2020

1 reference

Primary structure of the human muscle acetylcholine receptor. cDNA cloning of the gamma and epsilon subunits

31 March 2020

1 reference

Changes in serum complement activity in patients with myasthenia gravis

31 March 2020

1 reference

Auto-antibodies in Hashimoto's disease (lymphadenoid goitre)

31 March 2020

1 reference

31 March 2020

Affinity chromatography

1 reference

Autoimmune Response to Acetylcholine Receptor

31 March 2020

1 reference

Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice

31 March 2020

1 reference

Rat models as tool to develop new immunotherapies

31 March 2020

1 reference

Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor alpha-subunit

31 March 2020

1 reference

The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes

31 March 2020

1 reference

Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors

31 March 2020

1 reference

Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value

31 March 2020

1 reference

Myasthenia Gravis: Passive Transfer from Man to Mouse

31 March 2020

1 reference

Remission of myasthenia gravis following plasma-exchange

31 March 2020

1 reference

Function of circulating antibody to acetylcholine receptor in myasthenia gravis: Investigation by plasma exchange

31 March 2020

1 reference

Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis

31 March 2020

1 reference

Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor

31 March 2020

1 reference

Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies

31 March 2020

1 reference

Myasthenic Antibodies Cross-Link Acetylcholine Receptors to Accelerate Degradation

31 March 2020

1 reference

Autoimmune human T lymphocytes specific for acetylcholine receptor

31 March 2020

1 reference

Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls

31 March 2020

1 reference

Myasthenia gravis: recognition of a human autoantigen at the molecular level.

31 March 2020

1 reference

Autoimmune T cells in myasthenia gravis: heterogeneity and potential for specific immunotargeting

31 March 2020

1 reference

MYASTHENIA GRAVIS AND TUMORS OF THE THYMIC REGION: REPORT OF A CASE IN WHICH THE TUMOR WAS REMOVED

31 March 2020

1 reference

Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

31 March 2020

1 reference

TREATMENT OF MYASTHENIA GRAVIS WITH PHYSOSTIGMINE

31 March 2020

1 reference

Immunosuppressive treatments. Their efficacy on myasthenia gravis patients' outcome and on the natural course of the disease

31 March 2020

1 reference

Genetic associations between myasthenia gravis and the HL-A system

31 March 2020

1 reference

Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis

31 March 2020

1 reference

Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin

31 March 2020

1 reference

Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma

31 March 2020

1 reference

Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?

31 March 2020

1 reference

Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients

31 March 2020

1 reference

Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study

31 March 2020

1 reference

An acetylcholine receptor alpha subunit promoter confers intrathymic expression in transgenic mice. Implications for tolerance of a transgenic self-antigen and for autoreactivity in myasthenia gravis

31 March 2020

1 reference

Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology

31 March 2020

1 reference

Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations

31 March 2020

1 reference

Attempts to implicate viruses in myasthenia gravis

31 March 2020

1 reference

31 March 2020

1 reference

Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis

31 March 2020

1 reference

Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis

31 March 2020

1 reference

Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients

31 March 2020

1 reference

The generative grammar of the immune system. Nobel lecture, 8 December 1984.

31 March 2020

1 reference

Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus

31 March 2020

1 reference

Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichia coli, Proteus vulgaris, and Klebsiella pneumoniae. Possible role in the pathogenesis of myasthenia gravis

31 March 2020

1 reference

Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity

31 March 2020

1 reference

Clinical heterogeneity of seronegative myasthenia gravis

31 March 2020

1 reference

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

31 March 2020

1 reference

The agrin/muscle-specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction

31 March 2020

1 reference

Seronegative Myasthenia Gravis: Evidence for Plasma Factor(s) Interfering with Acetylcholine Receptor Function

31 March 2020

1 reference

Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function

31 March 2020

1 reference

Plasma from human mothers of fetuses with severe arthrogryposis multiplex congenita causes deformities in mice

31 March 2020

1 reference

Immunopathology of the Lambert-Eaton myasthenic syndrome

31 March 2020

1 reference

Potassium channel antibodies in two patients with reversible limbic encephalitis

31 March 2020

1 reference

Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels

31 March 2020

1 reference

Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis

31 March 2020

1 reference

GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis.

31 March 2020

1 reference

The role of antiglycolipid antibodies in peripheral neuropathies

31 March 2020

1 reference

Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies

31 March 2020

1 reference

Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies

31 March 2020

1 reference

Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self.

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRI916

1 reference

5 August 2017

1 reference